AZACTAM Side Effects

6882545-8 |
on Jul 22, 2010 Female patient from CANADA , 71 years of age, was diagnosed with bronchiectasis and was treated with Azactam (View Usage). . Azactam dosage: .

6783449-1 | Agranulocytosis, Pyrexia
Patient was taking Azactam (View Usage). Patient had the following side effects: agranulocytosis, pyrexia on Jun 17, 2010 from FRANCE Additional patient health information: Male patient , 73 years of age, was diagnosed with urinary tract infection pseudomonal and. Azactam dosage: . During the same period patient was treated with ALDACTONE (Film Coated Tablets) (View Aldactone Review and Aldactone Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), COLIMYCINE (View Colimycine Review and Colimycine Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), APROVEL (View Aprovel Review and Aprovel Label ), KREDEX (View Kredex Review and Kredex Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), AMINOGLYCOSIDES (View Aminoglycosides Review and Aminoglycosides Label ). Patient was hospitalized.

6692076-6 | Febrile Neutropenia, Rash, Renal Failure Acute
Adverse event was reported on Mar 26, 2010 by a Male patient taking Azactam (View Usage) (Dosage: Powder And Solvent For Soln For Inj/1000mg) was diagnosed with pyrexia and. Location: FRANCE , 68 years of age, After Azactam was administered, patient had the following side effects: febrile neutropenia, rash (What is rash?), renal failure acute. During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), CIPROFLOXACIN HCL (Inj) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ). Patient was hospitalized.

6687692-1 | Agranulocytosis, Pyrexia
on Apr 13, 2010 Male patient from FRANCE , 73 years of age, was diagnosed with urinary tract infection pseudomonal and was treated with Azactam (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, pyrexia. Azactam dosage: . During the same period patient was treated with ALDACTONE (Film Coated Tablets) (View Aldactone Review and Aldactone Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), COLIMYCINE (View Colimycine Review and Colimycine Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), APROVEL (View Aprovel Review and Aprovel Label ), KREDEX (View Kredex Review and Kredex Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), AMINOGLYCOSIDES (View Aminoglycosides Review and Aminoglycosides Label ). Patient was hospitalized.


6605020-4 | Arrhythmia
on Feb 19, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with meningitis (What is meningitis?) and was treated with Azactam (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?). Azactam dosage: . During the same period patient was treated with MAXIPIME (View Maxipime Review and Maxipime Label ).

6580512-5 | Ageusia, Decreased Appetite, Dysgeusia, Weight Decreased
Patient was taking Azactam (View Usage). After Azactam was administered, patient had the following side effects: ageusia, decreased appetite, dysgeusia, weight decreased on Oct 05, 2009 from UNITED STATES Additional patient health information: Female patient , 54 years of age, was diagnosed with spinal cord infection and. Azactam dosage: .

6580511-3 | Hypoalbuminaemia, Hypocalcaemia, Hypophosphataemia
Adverse event was reported on Jun 25, 2009 by a Female patient taking Azactam (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), sepsis (What is sepsis?) and. Location: UNITED STATES , 70 years of age, Patient experienced the following unwanted or unexpected effects: hypoalbuminaemia, hypocalcaemia, hypophosphataemia.

6336197-6 | Toxic Epidermal Necrolysis
on Aug 28, 2009 Male patient from SWITZERLAND , 43 years of age, was treated with Azactam (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Azactam dosage: Vials.. During the same period patient was treated with TIENAM (Vials.) (View Tienam Review and Tienam Label ), ROCEPHIN (Ampoules,iv.) (View Rocephin Review and Rocephin Label ), FLAGYL (Also Given From 04feb-06feb2009,3days;inf,ampoules Bags.) (View Flagyl Review and Flagyl Label ), CANCIDAS (Tablets,tongue Soluble;strength: 55.5mg.) (View Cancidas Review and Cancidas Label ), CYMEVENE (Vials) (View Cymevene Review and Cymevene Label ), TAVANIC (View Tavanic Review and Tavanic Label ), SOLU CORTEF (View Solu-cortef Review and Solu-cortef Label ), KONAKION (Konakion Mm;strength:10mg;vials.) (View Konakion Review and Konakion Label ).

6198428-5 | Chills, Dizziness, Fatigue, Headache, Malaise, Myalgia, Rash, Somnolence, Vomiting
on May 14, 2009 Female patient from FRANCE , 24 years of age, was diagnosed with cystic fibrosis and was treated with Azactam (View Usage). After Azactam was administered, patient had the following side effects: chills, dizziness (What is dizziness?), fatigue, headache (What is headache?), malaise, myalgia, rash (What is rash?), somnolence, vomiting. Azactam dosage: . During the same period patient was treated with AMIKACIN SULFATE (View Amikacin Sulfate Review and Amikacin Sulfate Label ), NEBCIN (Solution) (View Nebcin Review and Nebcin Label ), COLIMYCINE (View Colimycine Review and Colimycine Label ), FORTUM (View Fortum Review and Fortum Label ). Patient was hospitalized.

6130858-X | Toxic Epidermal Necrolysis
Patient was taking Azactam (View Usage). Patient experienced the following unwanted or unexpected effects: toxic epidermal necrolysis on Mar 19, 2009 from SWITZERLAND Additional patient health information: Male patient , 43 years of age, . Azactam dosage: Vials.. During the same period patient was treated with TIENAM (Vials.) (View Tienam Review and Tienam Label ), ROCEPHIN (Ampoules,iv.) (View Rocephin Review and Rocephin Label ), FLAGYL (Also Given From 04feb-06feb2009,3days;inf,ampoules Bags.) (View Flagyl Review and Flagyl Label ), CANCIDAS (Tablets,tongue Soluble;strength: 55.5mg.) (View Cancidas Review and Cancidas Label ), CYMEVENE (Vials) (View Cymevene Review and Cymevene Label ), TAVANIC (View Tavanic Review and Tavanic Label ), SOLU CORTEF (View Solu-cortef Review and Solu-cortef Label ), KONAKION (Konakion Mm;strength:10mg;vials.) (View Konakion Review and Konakion Label ).

5682749-6 | Infusion Site Erythema, Infusion Site Rash, Infusion Site Warmth, Rash Erythematous
Adverse event was reported on Mar 26, 2008 by a Female patient taking Azactam (View Usage) (Dosage: 2 Gm Every 8 Hours Iv) was diagnosed with osteomyelitis and. Location: UNITED STATES , 75 years of age, weighting 155.0 lb, Patient had the following side effects: infusion site erythema, infusion site rash, infusion site warmth, rash erythematous. During the same period patient was treated with VANCOMYCIN (1 Gm Every 18 Hours Iv) (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

5618282-7 | Oesophageal Pain
on Feb 06, 2008 Male patient from UNITED STATES , weighting 250.0 lb, was diagnosed with otitis externa and was treated with Azactam (View Usage). After Azactam was administered, patient had the following side effects: oesophageal pain. Azactam dosage: 2gm Every 8 Hours Iv Bolus. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), COLACE (View Colace Review and Colace Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ).

5601625-8 | Grand Mal Convulsion, Mental Impairment
on Dec 18, 2007 Female patient from UNITED STATES , 62 years of age, was diagnosed with pain (What is pain?) and was treated with Azactam (View Usage). Patient experienced the following unwanted or unexpected effects: grand mal convulsion, mental impairment. Azactam dosage: Received 30 Minutes Infusion.. During the same period patient was treated with DILANTIN (100mg Caps Take 2caps Qd Alternating With 3caps Ie 200mg 1day, Then 300mg The Next Then 200mg.) (View Dilantin Review and Dilantin Label ), FENTANYL TRANSDERMAL SYSTEM (View Fentanyl Transdermal System Review and Fentanyl Transdermal System Label ), VICODIN (500 - 1 To 2 Tabs Qid Prn) (View Vicodin Review and Vicodin Label ), IBUPROFEN (800mg Tabs Tid Prn) (View Ibuprofen Review and Ibuprofen Label ), FLEXERIL (1 Dosage Form = 1tabs. 1tab Q8hrs Prn) (View Flexeril Review and Flexeril Label ), ATIVAN (0.5mg Tid Prn) (View Ativan Review and Ativan Label ). Patient was hospitalized.

5601624-6 | Rash
Patient was taking Azactam (View Usage). Patient had the following side effects: rash (What is rash?) on May 23, 2007 from UNITED STATES Additional patient health information: Female patient , 36 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), respiratory disorder and. Azactam dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ).

5601623-4 | White Blood Cell Count Decreased
Adverse event was reported on Mar 16, 2007 by a Male patient taking Azactam (View Usage) (Dosage: ) was diagnosed with pneumonia (What is pneumonia?) and. Location: UNITED STATES , 31 years of age, After Azactam was administered, patient had the following side effects: white blood cell count decreased.

5601622-2 | Diplopia
on Feb 06, 2007 Male patient from UNITED STATES , 57 years of age, was diagnosed with infection (What is infection?) and was treated with Azactam (View Usage). Patient experienced the following unwanted or unexpected effects: diplopia. Azactam dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

5601620-9 | Nausea, Swelling Face, Throat Tightness
on Jan 19, 2007 Female patient from UNITED STATES , 32 years of age, was diagnosed with gram stain negative and was treated with Azactam (View Usage). Patient had the following side effects: nausea (What is nausea?), swelling face, throat tightness. Azactam dosage: . During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ).

5325936-9 | Gastrointestinal Disorder, Malaise, Myalgia
Patient was taking Azactam (View Usage). After Azactam was administered, patient had the following side effects: gastrointestinal disorder, malaise, myalgia on May 14, 2007 from UNITED STATES Additional patient health information: Male patient , 41 years of age, weighting 156.0 lb, was diagnosed with wound (What is wound?) and. Azactam dosage: 2gm Q6h Iv. During the same period patient was treated with STERILE WATER (View Sterile Water Review and Sterile Water Label ), SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

5273746-3 | Renal Failure Acute
Adverse event was reported on Mar 22, 2007 by a Female patient taking Azactam (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 82 years of age, Patient experienced the following unwanted or unexpected effects: renal failure acute.

5245121-9 | Aplastic Anaemia, Haemorrhage Intracranial, Toxic Epidermal Necrolysis
on Feb 13, 2007 Male patient from CHINA , 83 years of age, was treated with Azactam (View Usage). Patient had the following side effects: aplastic anaemia, haemorrhage intracranial, toxic epidermal necrolysis. Azactam dosage: . During the same period patient was treated with CEFODIZIME DISODIUM (Article Text States 1.0 G X 3/day, From 26-nov, But Table 1 States 2.0 G X 2/day, From 25-nov) (View Cefodizime Disodium Review and Cefodizime Disodium Label ), CHLORTETRACYCLINE HCL (View Chlortetracycline Hcl Review and Chlortetracycline Hcl Label ), LACTULOSE (View Lactulose Review and Lactulose Label ). Patient was hospitalized.

5233916-7 | Tinnitus
on Oct 31, 2006 Female patient from UNITED STATES , 44 years of age, was treated with Azactam (View Usage). After Azactam was administered, patient had the following side effects: tinnitus (What is tinnitus?). Azactam dosage: .

5233915-5 | Muscular Weakness, Myalgia
Patient was taking Azactam (View Usage). Patient experienced the following unwanted or unexpected effects: muscular weakness, myalgia on Aug 29, 2006 from UNITED STATES Additional patient health information: Female patient , 23 years of age, was diagnosed with pseudomonas infection and. Azactam dosage: . During the same period patient was treated with CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ).

5233914-3 | Blood Bilirubin Increased, Cholangitis, Hepatic Enzyme Increased
Adverse event was reported on Jul 21, 2006 by a Female patient taking Azactam (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 76 years of age, Patient had the following side effects: blood bilirubin increased, cholangitis, hepatic enzyme increased.

5233913-1 | Petechiae, Platelet Count Decreased
on Jun 08, 2006 Female patient from UNITED STATES , 68 years of age, was diagnosed with prophylaxis and was treated with Azactam (View Usage). After Azactam was administered, patient had the following side effects: petechiae, platelet count decreased. Azactam dosage: .

5233912-X | Skin Exfoliation
on Jan 20, 2006 Female patient from UNITED STATES , 81 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Azactam (View Usage). Patient experienced the following unwanted or unexpected effects: skin exfoliation. Azactam dosage: . Patient was hospitalized.

5221657-1 | Aplastic Anaemia, Dermatitis Exfoliative
Patient was taking Azactam (View Usage). Patient had the following side effects: aplastic anaemia, dermatitis exfoliative on Jan 23, 2007 from CHINA Additional patient health information: Male patient , 83 years of age, . Azactam dosage: .

4890764-5 | Hepatic Enzyme Increased, Urinary Tract Infection
Adverse event was reported on Jul 01, 2005 by a Male patient taking Azactam (View Usage) (Dosage: ) was diagnosed with pyelonephritis, urinary tract infection (What is urinary tract infection?) and. Location: UNITED STATES , 74 years of age, After Azactam was administered, patient had the following side effects: hepatic enzyme increased, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with TOPROL (View Toprol Review and Toprol Label ), MICARDIS (View Micardis Review and Micardis Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FOLTX (View Foltx Review and Foltx Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

4890763-3 | Rash
on Jan 20, 2005 Female patient from UNITED STATES , 71 years of age, was treated with Azactam (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Azactam dosage: .

4890762-1 | Rash
on Jan 12, 2005 Female patient from UNITED STATES , 75 years of age, was treated with Azactam (View Usage). Patient had the following side effects: rash (What is rash?). Azactam dosage: . During the same period patient was treated with LEVAQUIN (View Levaquin Review and Levaquin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ). Patient was hospitalized.

4846373-7 | Anuria, Creatinine Renal Clearance Decreased, Dermatitis Bullous, Multi-organ Failure, Pneumonitis, Rash, Toxic Skin Eruption
Patient was taking Azactam (View Usage). After Azactam was administered, patient had the following side effects: anuria, creatinine renal clearance decreased, dermatitis bullous, multi-organ failure, pneumonitis, rash (What is rash?), toxic skin eruption on Nov 24, 2005 from FRANCE Additional patient health information: Male patient , 51 years of age, was diagnosed with pneumonia (What is pneumonia?), endocarditis (What is endocarditis?) and. Azactam dosage: . During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), CIFLOX (View Ciflox Review and Ciflox Label ). Patient was hospitalized.

4826371-X | Skin Exfoliation
Adverse event was reported on Nov 01, 2005 by a Female patient taking Azactam (View Usage) (Dosage: ) was diagnosed with lung infection, cystic fibrosis, staphylococcal infection (What is staphylococcal infection?) and. Location: UNITED KINGDOM , 14 years of age, weighting 99.21 lb, Patient experienced the following unwanted or unexpected effects: skin exfoliation. During the same period patient was treated with TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), COLOMYCIN (View Colomycin Review and Colomycin Label ), CREON (View Creon Review and Creon Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ), DORNASE ALFA (View Dornase Alfa Review and Dornase Alfa Label ), SALBUTAMOL (View Salbutamol Review and Salbutamol Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ).

4733293-1 | Cardiac Failure, Cerebral Infarction, Convulsion, Disseminated Intravascular Coagulation, Hepatic Function Abnormal, Multi-organ Failure, Myocardial Infarction, Renal Impairment
on Jul 01, 2005 Female patient from JAPAN , 90 years of age, was diagnosed with pneumonia (What is pneumonia?), respiratory moniliasis, angina pectoris, gastric ulcer, asthma (What is asthma?) and was treated with Azactam (View Usage). Patient had the following side effects: cardiac failure, cerebral infarction, convulsion, disseminated intravascular coagulation, hepatic function abnormal, multi-organ failure, myocardial infarction, renal impairment. Azactam dosage: . During the same period patient was treated with PRODIF (23-mar-2005 To 24-mar-2005 200 Mg/day, Then 25-mar-2005 To 11-apr-2005 100 Mg/day) (View Prodif Review and Prodif Label ), DYPYRIDAMOLE (View Dypyridamole Review and Dypyridamole Label ), ALANTA (View Alanta Review and Alanta Label ), COUGHNOL (View Coughnol Review and Coughnol Label ), GASTER (View Gaster Review and Gaster Label ), CRAVIT (View Cravit Review and Cravit Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ).

4714477-5 | Multi-organ Failure
on Jul 01, 2005 Female patient from JAPAN , 90 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Azactam (View Usage). After Azactam was administered, patient had the following side effects: multi-organ failure. Azactam dosage: . During the same period patient was treated with PRODIF (View Prodif Review and Prodif Label ).

4704988-0 | Carnitine Decreased, Haemorrhage, Hepatic Failure, Hepatitis Fulminant, Lactic Acidosis, Shock Haemorrhagic
Patient was taking Azactam (View Usage). Patient experienced the following unwanted or unexpected effects: carnitine decreased, haemorrhage, hepatic failure, hepatitis fulminant, lactic acidosis, shock haemorrhagic on Jun 20, 2005 from FRANCE Additional patient health information: Male patient , 45 years of age, . Azactam dosage: . During the same period patient was treated with EUPANTOL (View Eupantol Review and Eupantol Label ), ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CANCIDAS (Dates Of Administration: 08-apr-2005 To 13-apr-2005, 02-may-2005 To 16-may-2005.) (View Cancidas Review and Cancidas Label ). Patient was hospitalized.

4704068-4 | Polyneuropathy
Adverse event was reported on May 12, 2005 by a Male patient taking Azactam (View Usage) (Dosage: ) . Location: , 53 years of age, Patient had the following side effects: polyneuropathy. During the same period patient was treated with FOSFOCINE (View Fosfocine Review and Fosfocine Label ), LASIX (View Lasix Review and Lasix Label ), OFLOCET (View Oflocet Review and Oflocet Label ), ARANESP (View Aranesp Review and Aranesp Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

4662756-2 | Deafness, Tinnitus
on May 05, 2005 Female patient from , 34 years of age, was treated with Azactam (View Usage). After Azactam was administered, patient had the following side effects: deafness, tinnitus (What is tinnitus?). Azactam dosage: . During the same period patient was treated with AMINOGLYCOSIDES (View Aminoglycosides Review and Aminoglycosides Label ).

4636505-8 | Headache, Oedema Mouth, Oral Discomfort, Oral Pain, Pyrexia
on Apr 06, 2005 Female patient from , child 12 years of age, was diagnosed with increased bronchial secretion, asthenia and was treated with Azactam (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), oedema mouth, oral discomfort, oral pain, pyrexia. Azactam dosage: . During the same period patient was treated with NEBCINA (View Nebcina Review and Nebcina Label ). Patient was hospitalized.

4590460-8 | Activated Partial Thromboplastin Time Prolonged, Epistaxis
Patient was taking Azactam (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, epistaxis on Feb 14, 2005 from Additional patient health information: Female patient , 78 years of age, . Azactam dosage: . During the same period patient was treated with HEPARIN (Dosage Form = Unit) (View Heparin Review and Heparin Label ).